AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Pulmonx Corp (LUNG) Shares Soar 11.8% on Strong Q1 Earnings
Generated by AI AgentAinvest Movers Radar
Thursday, May 1, 2025 5:09 am ET1min read
Pulmonx Corp (LUNG) shares surged 11.8% in pre-market trading on May 1, 2025, driven by strong first-quarter financial results.
Pulmonx reported a 20% increase in total revenue for the first quarter of 2025, reaching $22.5 million. This growth was fueled by a 39% increase in international revenue and an 11% increase in U.S. revenue. The company's marketing and peer-to-peer education efforts were highlighted as key contributors to this success.
CEO Steve Williamson emphasized that
achieved worldwide sales of $22.5 million in Q1 2025, representing a 20% growth year-over-year. This performance aligns with the company's projection of 20% long-term growth, driven by its expanded product offerings and strategic initiatives.Pulmonx's strong Q1 performance has positioned the company for continued growth in 2025. The company's projected full-year revenue range of $96 million to $98 million reflects anticipated growth of 15% to 17% over 2024. This outlook, combined with the company's innovative treatments for severe emphysema, has bolstered investor confidence in Pulmonx's future prospects.
Ainvest Movers Radar
Knowing stock market today at a glance
Latest Articles
Sharp Downturn in LENZ.O: What's Behind the 29% Intraday Drop?
Dec.12 2025
Quanex (NX.N) Spikes 9% on Inverse Head-and-Death Cross Amid Divergent Peer Moves
Dec.12 2025
Why Did BTQ.O Drop 6.4% Without Major News?
Dec.12 2025
Gogo (GOGO.O) Sharp Intraday Drop: Technical, Order Flow, and Peer Analysis
Dec.12 2025
Unpacking the Sudden 5.1% Rally in Churchill X (CCCX.O): A Deep Dive
Dec.12 2025
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet